Research focused on public health aspects of virology, pathogenesis and new and emerging diseases. It includes an in vivo and in vitro capability with highly pathogenic viruses at high containment and a surveillance programme on emerging diseases.

Major focus is to understand the mechanism behind pathogenesis and developing new, next generation vaccine candidate such as DNA and Adenovirus platforms, for human respiratory and highly pathogenic viral zoonoses, including Crimean Congo Hemorrhagic Fever Virus, Lassa and Marburg Viruses and Tick vaccines. The vaccine candidates will not only be developed for human use but also for domestic animals in endemic and non-endemic areas.